The Royal Marsden, Chelsea

The Royal Marsden (Chelsea), on Fulham Road in London, is the flagship site of The Royal Marsden NHS Foundation Trust. Founded in 1851, it was the first hospital in the world dedicated exclusively to cancer research, diagnosis and treatment.

It is consistently ranked by Newsweek among the leading specialist cancer hospitals in the world, and is rated "Outstanding" by the UK Care Quality Commission (CQC). It works in direct partnership with The Institute of Cancer Research (ICR), forming one of the leading comprehensive cancer centres in the world. It specialises in bench-to-bedside clinical trials and pioneering precision medicine.

It treats the full range of adult and childhood cancers, with world-leading drug development units, targeted immunotherapy, advanced chemotherapy, precision radiotherapy, and a dedicated bone marrow transplant unit.

Advanced radiotherapy: High-precision image-guided radiotherapy (IGRT), stereotactic ablative radiotherapy (SABR), and dedicated platforms including the CyberKnife and TrueBeam linear accelerators.

Surgical oncology: State-of-the-art cancer surgery using advanced minimally invasive and robot-assisted equipment.